<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>QUANTUMZYME RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Wed, 03 Jun 2026 21:28:12 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/quantumzyme%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>QUANTUMZYME RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>EQS-News: Quantum Genesis AI Announces Removal of OTC Markets Caveat Emptor Designation</title><pubDate>Mon, 01 Jun 2026 18:49:01 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-quantum-genesis-ai-announces-removal-of-otc-markets-caveat-emptor-designation-15722032</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: Quantum Genesis AI Corp


 / Key word(s): Manufacturing


<br/>


Quantum Genesis AI Announces Removal of OTC Markets Caveat Emptor Designation <br/><br/>01.06.2026 / 18:49  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-quantum-genesis-ai-announces-removal-of-otc-markets-caveat-emptor-designation-15722032</guid></item><item><title>EQS-News: Quantum Genesis AI Issues Clarification Regarding Research Activities and Intellectual Property</title><pubDate>Tue, 19 May 2026 21:11:11 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-quantum-genesis-ai-issues-clarification-regarding-research-activities-and-intellectual-property-15698271</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: Quantum Genesis AI Corp


 / Key word(s): Public Policy/Govt


<br/>


Quantum Genesis AI Issues Clarification Regarding Research Activities and Intellectual Property <br/><br/>19.05.2026  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-quantum-genesis-ai-issues-clarification-regarding-research-activities-and-intellectual-property-15698271</guid></item><item><title>EQS-News: Quantum Genesis AI Corp. Issues Statement Regarding OTC Markets Caveat Emptor Designation</title><pubDate>Thu, 12 Mar 2026 18:55:31 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-quantum-genesis-ai-corp-issues-statement-regarding-otc-markets-caveat-emptor-designation-15552818</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/quantumzyme-aktie">Quantumzyme</a> Corp


 / Key word(s): Science


<br/>


Quantum Genesis AI Corp. Issues Statement Regarding OTC Markets Caveat Emptor  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-quantum-genesis-ai-corp-issues-statement-regarding-otc-markets-caveat-emptor-designation-15552818</guid></item><item><title>EQS-News: Quantumzyme Research Published in the Journal of Molecular Graphics amp; Modelling Study Highlights In Silico Enzyme Engineering Approach for Sustainable Drug Manufacturing</title><pubDate>Thu, 12 Feb 2026 13:21:41 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-research-published-in-the-journal-of-molecular-graphics-amp-amp-modelling-study-highlights-in-silico-enzyme-engineering-approach-for-sustainable-drug-manufacturing-15484675</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/quantumzyme-aktie">Quantumzyme</a> Corp


 / Key word(s): Manufacturing


<br/>


Quantumzyme Research Published in the Journal of Molecular Graphics amp;amp;  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-research-published-in-the-journal-of-molecular-graphics-amp-amp-modelling-study-highlights-in-silico-enzyme-engineering-approach-for-sustainable-drug-manufacturing-15484675</guid></item><item><title>EQS-News: Quantumzyme Announces Strategic Capital Structure Initiative, Corporate Rebranding Update, and Planned 4-for-1 Forward Stock Split</title><pubDate>Mon, 09 Feb 2026 14:01:11 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-announces-strategic-capital-structure-initiative-corporate-rebranding-update-and-planned-4-for-1-forward-stock-split-15473848</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/quantumzyme-aktie">Quantumzyme</a> Corp


 / Key word(s): Manufacturing


<br/>


Quantumzyme Announces Strategic Capital Structure Initiative, Corporate  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-announces-strategic-capital-structure-initiative-corporate-rebranding-update-and-planned-4-for-1-forward-stock-split-15473848</guid></item><item><title>EQS-News: Quantumzyme Featured on Cover of RSC Sustainability for Research in Enzyme Engineering for Ibuprofen Synthesis</title><pubDate>Fri, 30 Jan 2026 13:05:31 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-featured-on-cover-of-rsc-sustainability-for-research-in-enzyme-engineering-for-ibuprofen-synthesis-15449161</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/quantumzyme-aktie">Quantumzyme</a> Corp


 / Key word(s): Science


<br/>


Quantumzyme Featured on Cover of RSC Sustainability for Research in Enzyme  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-featured-on-cover-of-rsc-sustainability-for-research-in-enzyme-engineering-for-ibuprofen-synthesis-15449161</guid></item><item><title>EQS-News: Quantumzyme to Attend 2026 BIO International Convention</title><pubDate>Wed, 28 Jan 2026 13:20:41 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-to-attend-2026-bio-international-convention-15442042</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/quantumzyme-aktie">Quantumzyme</a> Corp


 / Key word(s): Manufacturing


<br/>


Quantumzyme to Attend 2026 BIO International Convention <br/><br/>28.01.2026  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-to-attend-2026-bio-international-convention-15442042</guid></item><item><title>EQS-News: UPDATE: Quantumzyme Announces Next-Generation Enzyme Engineering Platform for More Efficient Pharmaceutical Manufacturing</title><pubDate>Tue, 27 Jan 2026 15:07:21 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-update-quantumzyme-announces-next-generation-enzyme-engineering-platform-for-more-efficient-pharmaceutical-manufacturing-15439110</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/quantumzyme-aktie">Quantumzyme</a> Corp


 / Key word(s): Manufacturing


<br/>


UPDATE: Quantumzyme Announces Next-Generation Enzyme Engineering Platform  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-update-quantumzyme-announces-next-generation-enzyme-engineering-platform-for-more-efficient-pharmaceutical-manufacturing-15439110</guid></item><item><title>EQS-News: Quantumzyme Announces Next-Generation Enzyme Engineering Platform for More Efficient Pharmaceutical Manufacturing</title><pubDate>Tue, 27 Jan 2026 13:48:51 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-announces-next-generation-enzyme-engineering-platform-for-more-efficient-pharmaceutical-manufacturing-15438895</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/quantumzyme-aktie">Quantumzyme</a> Corp


 / Key word(s): Manufacturing


<br/>


Quantumzyme Announces Next-Generation Enzyme Engineering Platform for  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-announces-next-generation-enzyme-engineering-platform-for-more-efficient-pharmaceutical-manufacturing-15438895</guid></item><item><title>EQS-News: Quantumzyme Corp. Provides 2025 Corporate Update and Outlines Strategic Priorities for 2026</title><pubDate>Mon, 26 Jan 2026 15:17:13 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-corp-provides-2025-corporate-update-and-outlines-strategic-priorities-for-2026-15436352</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/quantumzyme-aktie">Quantumzyme</a> Corp


 / Key word(s): Manufacturing


<br/>


Quantumzyme Corp. Provides 2025 Corporate Update and Outlines Strategic  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-quantumzyme-corp-provides-2025-corporate-update-and-outlines-strategic-priorities-for-2026-15436352</guid></item></channel></rss>
